Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[Pacak and Brown, in press]
Paraganglioma syndromes: what's new? K Pacak, MJ Brown.
[Willem de Herder, in press]
New options in investigation and management of carcinoid syndrome. W Willem de Herder.
[Fassnacht, in press]
New strategies for adrenal cancer. M Fassnacht.
[Grossman, in press]
Issues in the management of MEN2. A Grossman.
[Lyman Clarke, in press]
Subclinical hormone excess & the adrenal incidentaloma. F Mantero. MEN1 syndrome & the best approach to PTH excess. B Lyman Clarke.
[OR15-5]
Somatostatin receptor targeted photodynamic therapy: in vitro targeting of sst2 expressing tumor cells with photosensitizer-coupled somatostatin analogs. LJ Hofland, Y Ye, S Achilefu, K van der Wansem, PM van Koetsveld, AJ van der Lelij, et al.
[P1-114]
Association of somatostatin receptor 2 immunohistochemical expression with imaging findings in 111In-DTPA octreotide scintigraphy and 68Ga-DOTATOC PET/CT in neuroendocrine tumors. K Mussig, B Gallwitz, K Dudziak, B Ueberberg, MO Oksuz, M Wehrmann, et al.
[P1-119]
Possible positive feedback observed both in vivo and in vitro in a case of ectopic ACTH syndrome. H Koso, K Morita, M Konishi, K Hamano, H Asano, Y Ozeki, et al.
[P1-120]
Small-cell carcinoma of the endometrium presenting as cushing's syndrome. H Sato, H Kajiwara, RY Osamura.
[P1-121]
Cushing's syndrome from ectopic CRH and ACTH production by a pheochromocytoma in a patient with multiple endocrine neoplasia type II B (MEN IIB). SA Al-Ansari, C Chik.
[P1-122]
A tale of three clinically functioning adrenocortical carcinomas. JF Robles, EC Cunanan, AA Andag-Silva, LB Mercado-Asis.
[P1-123]
Pregnancy and insulinoma: a complex management challenge. AO Lungu, M Khan, C Cochran, F Pucino, P Gorden.
[P1-124]
Continuous glucagon infusion and hepatic arterial chemoembolization used to manage severe refractory hypoglycemia in a patient with metastatic insulinoma. E Briggs, R Horenstein.
[P1-125]
Metastatic pancreatic neuroendocrine tumors: phenotypic switching producing novel hormonal syndromes. M Gladysz, N Markelova, GG Fareau.
[P1-126]
A long-term follow up of a rare case of somatostatin-producing metastatic neuroendocrine tumor. BR Shastri, DE Scarborough.
[P1-127]
Pure postprandial hypoglycemia: is insulinoma still in the differential? MS Sivanandy, SR Gordon, EK Hoffer, RJ Barth, Jr., RJ Comi.
[P1-128]
Non-islet cell tumour hypoglycaemia (NICTH) associated with gastro-oesophageal junctional adenocarcinoma. NL Reddy, TM Barber, R Maxwell, G Brierley, K Hyde, S Kayani, et al.
[P1-129]
Postprandial hypoglycemia as the main clinical feature of an insulinoma. E Lee, V Savarese, S Jabbour.
[P1-130]
An unusual case of insulin-secreting carcinoid tumor. LA Nabbout, DE Lehane, DJ Hamilton.
[P1-131]
Cardiac pheochromocytoma presenting during pregnancy. LA Fraser, B Kiaii, J Shaban, A Islam, P Diamantouros, PM Jones, et al.
[P1-132]
Octreotide: the solution to severe recalcitrant neuroglycopenia in association with glibenclamide overdose. HT Khor, R Dalan,AK Pandey, P Surampudi, J Waddadar.
[P1-145]
A rare case of a composite adrenal medullary neoplasm: a case report. J Waddadar, PN Surampudi, AK Pandey, C McCarty, A Bohlke, J Wani, et al.
[P1-146]
Pathologic malignant bilateral pheochromocytoma in von-Hippel-Lindau disease associated with Graves’ disease.
[P1-151]
Ectopic acromegaly caused by a GHRH-secreting bronchial carcinoid tumor in a type 1 diabetic patient. PW Butler, CS Cochran, P Gorden.
[P1-152]
Metastatic atypical bronchial carcinoid presenting as ectopic ACTH-dependent Cushing's syndrome in a 26 y/o war veteran: lessons learned. GD Shull, H Hussain, WL Fowler, Jr.
[P2-93]
IGF1R Gene overexpression in sporadic adrenocortical tumors is not dependent on gene amplification. TC Ribeiro, MQ Almeida, AA Jorge, BMP Mariani, MC Fragoso, BB Mendonca, et al.
[P2-94]
Effect of universal somatostatin analog (SOM230) on primary adrenal cell cultures. B Mariniello, I Finco, B Rubin, A Patalano, S Ferrasin, M Iacobone, et al.
[P2-95]
Evidence in favor of a multi-step model of adrenocortical tumor development. M Herbet, J-JJ Feige, M Thomas.
[P2-101]
Impaired transforming growth factor-beta (TGF-beta) transcriptional activity and cell proliferation control of a menin in-frame deletion mutant associated with multiple endocrine neoplasia type 1 (MEN1). L Canaff, J-F Vanbellinghen, D Goltzman, GN Hendy.
[P2-102]
The novel somatostatin analogue som230 inhibits cell proliferation and cholecystokinin secretion in stc-1 neuroendocrine cells. P Dalino Ciaramella, M Ruscica, E Grossrubatscher, E Dozio, D Feltrin, A Orlando, et al.
[P2-103]
Effect of lanreotide, cabergoline and somatostatin-dopamine chimeric molecules on hormone secretion and cell proliferation in medullary thyroid cancer: an in vitro study. R Pivonello, C Pivonello, G Petrillo, MC De Martino, A Faggiano, M Culler, et al.
[P2-104]
FGFR4 Gly/Arg388 polymorphism plays a key role in the progression of a model of neuroendocrine carcinoma. S Serra, L Zheng, S Cheng, S Ezzat, SL Asa.
[P2-105]
Development of a novel anti-IGF1 receptor immunoliposomal cancer therapy with enhanced therapeutic efficiency. C Hantel, F Lewrick, S Schneider, O Zwermann, M Reincke, R Peschka-Suess, et al.
[P2-107]
Anaemic tendency in subjects with heterozygous germ-line VHL mutations. U Srirangalingam, M Patel, SL Chew.
[P2-109]
GLUT5: novel target in pancreatic cancer. H Liu, D Huang, H Hui, A Heaney.
[P2-110]
Quantitative analysis of transcripts and parafibromin expression resulted from aberrant splicing of HRPT2 in hyperparathyroidism-jaw tumor syndrome. S-D Moon, J-H Kim, J-Y Shim, Y-B Ahn, B-Y Cha, J-H Han.
[P2-660]
Suspected MEN1 like syndrome in association with a carcinoid tumour. RP Narayanan, H White, H Wieshmann, G Poston, I MacFarlane, D Cuthbertson.
[P2-681]
Adrenal mass in a patient with combined 17 alpha-hydroxylase/17,20 lyase deficiency. DSA Vieira, ESL Oliveira, VS Lando, LAC Neves, LR Salgado, S Domenice, et al.
Copyright © 2010. Sociedad Española de Endocrinología y Nutrición
